Streamline Your Antibody Discovery Workflow
Application Note Mar 11, 2019
Monoclonal antibodies are one of the fastest-growing classes of biopharmaceuticals and are the backbone of many treatment modalities.
Many antibodies engage the same target or target multple members of a single signaling pathway, therfore drug developers are pushing to produce next generation antibody drugs against new targets with improved mechanisms of action, pharmacokinetics and delivery systems. The Intellicyt® iQue Screener platform provides an integrated solution that produces rapidly acrtionable results.
Download this application note to discover how you can:
- Deliver rich content with lower sampling times
- Reduce assay volumes and save cell and reagent costs
- Dramatically reduce time and effort to generate useful results